ARUN KANTAMNENI: Open Payments
NPI 1962659391 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 34 payments from 10 companies in 2025. Trend: 2023 $735 · 2024 $655 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $163 |
| ABBVIE INC. | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| Neuronetics, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Tris Pharma Inc | 1 | $25 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: SPRAVATO, VRAYLAR, REXULTI, CAPLYTA, Jornay PM, INVEGA SUSTENNA, NEUROSTAR TMS THERAPY SYSTEM, Auvelity.
Industry payments across GA — which companies pay providers there.
